Systemic Hypertension
ISSN 2075-082X (Print)
ISSN 2542-2189 (Online)
Menu
Archives
Home
About the Journal
Editorial Policies
Author Guidelines
About the Journal
Issues
Search
Current
Articles in press
Archives
Contact
Subscriptions
Editorial Board
All Journals
User
Username
Password
Remember me
Forgot password?
Register
Notifications
View
Subscribe
Search
Search
Search Scope
All
Authors
Title
Abstract
Index terms
Full Text
Browse
By Issue
By Author
By Title
Other Journals
Categories
Keywords
amlodipine
antihypertensive therapy
arterial hypertension
blood pressure
chronic heart failure
diabetes mellitus
diuretics
endothelial dysfunction
hydrochlorothiazide
hypertension
metabolic syndrome
obesity
perindopril
pulmonary arterial hypertension
pulmonary hypertension
risk factors
антигипертензивная терапия
артериальная гипертензия
артериальная гипертония
метаболический синдром
сахарный диабет
×
User
Username
Password
Remember me
Forgot password?
Register
Notifications
View
Subscribe
Search
Search
Search Scope
All
Authors
Title
Abstract
Index terms
Full Text
Browse
By Issue
By Author
By Title
Other Journals
Categories
Keywords
amlodipine
antihypertensive therapy
arterial hypertension
blood pressure
chronic heart failure
diabetes mellitus
diuretics
endothelial dysfunction
hydrochlorothiazide
hypertension
metabolic syndrome
obesity
perindopril
pulmonary arterial hypertension
pulmonary hypertension
risk factors
антигипертензивная терапия
артериальная гипертензия
артериальная гипертония
метаболический синдром
сахарный диабет
Home
>
Search
>
Author Details
Author Details
Zhernakova, Yu V
Issue
Section
Title
File
Vol 7, No 1 (2010)
Articles
Znachenie agonista imidazolinovykh retseptorov moksonidina v lechenii bol'nykh arterial'noy gipertoniey i metabolicheskim sindromom. Rezul'taty issledovaniya MERSY v Rossii
Vol 8, No 2 (2011)
Articles
Svyaz' chisla komponentovmetabolicheskogo sindromas rasprostranennost'yui vyrazhennost'yu porazheniyaorganov-misheney
Vol 10, No 4 (2013)
Articles
The prevalence of arterial hypertension as a risk factor of cardiovascular diseases in one of the cities in Siberian Federal District
Vol 10, No 4 (2013)
Articles
Coagulogic risk factors of heart disease in the adult population of Tomsk
Vol 11, No 1 (2014)
Articles
Hypertension treatment features in perimenopausal women
(Rus)
Vol 11, No 1 (2014)
Articles
Risk of target organ damage in patients with arterial hypertension and various numbers of metabolic syndrome components
(Rus)
Vol 11, No 2 (2014)
Articles
Recommendations on treatment strategies in hypertensivepatientswithmetabolic disorders
(Rus)
Vol 11, No 4 (2014)
Articles
The prevalence of carotid atherosclerosis in spontaneous populations in Tomsk
(Rus)
Vol 11, No 4 (2014)
Articles
The state of the vascular wall in adult population of Tomsk in the framework of the project ESSAY RF
(Rus)
Vol 12, No 2 (2015)
Articles
Calcium channel blockers: more than 50 years on guard of health
(Rus)
Vol 12, No 1 (2015)
Articles
The role of beta-blockers in the treatment of arterial hypertension: what do we know today
(Rus)
Vol 12, No 3 (2015)
Articles
Experts of RMSAH opinion: the fixed combination of azilsartan medoxomil and chlortalidone is broadening options of the combined therapyin patients with arterial hypertension
(Rus)
Vol 12, No 1 (2015)
Articles
Patients with arterial hypertension associated with metabolic disorders: characteristics and therapeutic approach
(Rus)
Vol 13, No 3 (2016)
Articles
The possibility of a new receptor blocker to angiotensin in improving control of hypertension. Non-intervention international multicenter observational prospective study of the use azilsartan medoxomil in patients with arterial hypertension and overweight or obesity in the Russian Federation and the Republic of Kazakhstan
(Rus)
Vol 13, No 3 (2016)
Articles
Control of cardiovascular risk in patients with diabetes
(Rus)
Vol 14, No 1 (2017)
Articles
Cardiovascular risk factors in people with high normal blood pressure in Russian population (based on data obtained in ESSE-RF epidemiological study)
(Rus)
Vol 13, No 4 (2016)
Articles
The patients of high cardiovascular risk of healthy: unrecognized metabolic syndrome
(Rus)
Vol 14, No 1 (2017)
Articles
Fixed combination of highly selective β-adrenoblocker bisoprolol and calcium antagonist amlodipine (Concor® AM) for arterial hypertension treatment in metabolic disorder patients
(Rus)
Vol 14, No 3 (2017)
Articles
The new angiotensin II receptor blocker Edarbi® as part of the pathogenetic treatment of arterial hypertension in patients with metabolic disorders
(Rus)
Vol 15, No 1 (2018)
Articles
The prevalence of diabetes mellitus in population of hypertensive patients according to ESSE RF study results
(Rus)
Vol 15, No 3 (2018)
Articles
Guidelines for diagnostics and treatment of hypertension 2018 - European experts’opinion [Guidelines]
(Rus)
Vol 15, No 3 (2018)
Articles
Obesity as a predictor for cardiovascular disease development: role of localized fat depot
(Rus)
Vol 15, No 4 (2018)
Articles
Polypill" conception in modern cardiology
(Rus)
Vol 15, No 4 (2018)
Articles
Epicardial fat: a new cardiometabolic risk marker, a new therapeutic goal in obese patients
(Rus)
Vol 15, No 4 (2018)
Articles
Communication of subcutaneous, visceral, periaortic, epicardial fat and metabolic parameters with arterial stiffness in young people with abdominal obesity
(Rus)
Vol 6, No 4 (2009)
Articles
The improved form perindopril in treatment of arterial hypertension in various clinical situations (PREMIA)
Vol 8, No 1 (2011)
Articles
Tyazhest' metabolicheskogo sindroma opredelyaetsya chislom ego komponentov.
Vol 8, No 3 (2011)
Articles
Vliyanie chisla odnovremennovstrechayushchikhsya komponentovmetabolicheskogo sindroma na tyazhest'arterial'noy gipertonii,rasprostranennost' i vyrazhennost'porazheniya organov-misheneyu dannykh bol'nykh
Vol 8, No 4 (2011)
Articles
Vliyanie stepeni narusheniy uglevodnogo obmena na tyazhest' arterial'noy gipertonii, rasprostranennost' i vyrazhennost' porazheniya organov-misheney u bol'nykh s metabolicheskim sindromom
Vol 16, No 1 (2019)
Articles
Diagnosis and treatment of arterial hypertension [Guidelines]
(Rus)
This website uses cookies
You consent to our cookies if you continue to use our website.
About Cookies
TOP